Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER
NCT ID: NCT03068130
Last Updated: 2025-06-11
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE3
261 participants
INTERVENTIONAL
2017-04-18
2020-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT
NCT02036970
Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST
NCT02657356
A Study With BPS-314d-MR-PAH-303 in Participants With Pulmonary Arterial Hypertension
NCT03657095
Comparison of Vasodilator Response of Inhaled Epoprostenol and Inhaled Nitric Oxide
NCT04231084
Open-Label Extension Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
NCT02736149
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Qualified patients will receive 10 mg of bardoxolone methyl once daily until the drug is available through commercial channels or until patient withdrawal, whichever is sooner. Dose de-escalation (down to 5 mg) is permitted during the study, if indicated clinically.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bardoxolone methyl 10 mg
Bardoxolone methyl will be administered orally once daily at 10 mg until it becomes commercially available. Dose de-escalation (down to 5 mg) is permitted during the study, if indicated clinically.
Bardoxolone methyl
Capsules of Bardoxolone methyl
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bardoxolone methyl
Capsules of Bardoxolone methyl
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients who have an ongoing SAE from a clinical study that is assessed by the investigator as related to bardoxolone methyl;
* Unwilling to practice acceptable methods of birth control (both males who have partners of childbearing potential and females of childbearing potential) while taking study drug;
* Women who are pregnant or breastfeeding;
* Patient is, in the opinion of the investigator, unable to comply with the requirements of the study protocol or is unsuitable for the study for any reason;
* Known hypersensitivity to any component of the study drug
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Biogen
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Banner University Medical Center, Phoenix Advanced Lung Disease Institute
Phoenix, Arizona, United States
Arizona Pulmonary Specialists
Phoenix, Arizona, United States
Cedars Sinai Medical Center
Beverly Hills, California, United States
University of California San Diego
La Jolla, California, United States
VA Healthcare System of Greater Los Angeles
Los Angeles, California, United States
David Geffen School of Medicine UCLA
Los Angeles, California, United States
University of California Davis Medical Center - Division of Pulmonary and Critical Care
Sacramento, California, United States
Harbor - UCLA Medical Center
Torrance, California, United States
University of Colorado Denver - Division of Pulmonary Sciences
Aurora, Colorado, United States
Georgetown University Medical Center - Department of Rheumatology
Washington D.C., District of Columbia, United States
University of Miami Miller School of Medicine
Miami, Florida, United States
Cleveland Clinic of Florida
Weston, Florida, United States
Augusta University
Augusta, Georgia, United States
Piedmont-Georgia Lung
Austell, Georgia, United States
Northwestern Memorial Hospital
Chicago, Illinois, United States
University of Illinois at Chicago
Chicago, Illinois, United States
University of Chicago
Chicago, Illinois, United States
Kentuckiana Pulmonary Associates
Louisville, Kentucky, United States
Maine Medical Center - Division of Pulmonary and Critical Care Medicine
Portland, Maine, United States
Tufts Medical Center
Boston, Massachusetts, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Brigham and Women's Hospital
Boston, Massachusetts, United States
Boston University School of Medicine
Boston, Massachusetts, United States
University of Michigan
Ann Arbor, Michigan, United States
Washington University School of Medicine
St Louis, Missouri, United States
University of New Mexico Health Sciences Center
Albuquerque, New Mexico, United States
Winthrop University Hospital
Mineola, New York, United States
NYU Langone Medical Center
New York, New York, United States
University of Rochester - University of Rochester Medical Center
Rochester, New York, United States
Duke University Medical Center
Durham, North Carolina, United States
The Lindner Clinical Trial Center
Cincinnati, Ohio, United States
University of Cincinnati - Department of Internal Medicine Pulmonary, Critical Care & Sleep Medicine
Cincinnati, Ohio, United States
Cleveland Clinic
Cleveland, Ohio, United States
The Ohio State University Wexner Medical Center
Columbus, Ohio, United States
Oklahoma Heart Hospital
Oklahoma City, Oklahoma, United States
Oregon Health & Science University
Portland, Oregon, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Thomas Jefferson University
Philadelphia, Pennsylvania, United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
Medical University of South Carolina
Charleston, South Carolina, United States
University of Texas Southwestern Medical Center
Dallas, Texas, United States
The Methodist Hospital Research Institute
Houston, Texas, United States
The University of Texas - Health Science Center & Medical School at Houston
Houston, Texas, United States
University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics
Houston, Texas, United States
University of Utah
Salt Lake City, Utah, United States
Aurora Health Care
Milwaukee, Wisconsin, United States
Centro Médico Dra de Salvo
Buenos Aires, Ciudad Autónoma de BuenosAires, Argentina
Instituto de Investigaciones Clínicas Mar Del Plata
Buenos Aires, Mar Del Plata, Argentina
Instituto de Cardiologia de Corrientes Juana Francisca Cabral
Corrientes, , Argentina
Hospital Privado Centro Médico de Córdoba
Córdoba, , Argentina
Instituto Cardiovascular de Rosario
Rosario, , Argentina
Hospital Provincial Dr Jose Maria Cullen
Santa Fe, , Argentina
St Vincent's Hospital Sydney
Darlinghurst, New South Wales, Australia
John Hunter Hospital
New Lambton, New South Wales, Australia
Princess Alexandra Hospital
Brisbane, Queensland, Australia
Royal Hobart Hospital
Hobart, Tasmania, Australia
UZ Leuven
Leuven, Vlaams Brabant, Belgium
Hospital Erasme
Brussels, , Belgium
Irmandade Da Santa Casa de Misericordia de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
Hospital Dia do Pulmão
Blumenau, Santa Catarina, Brazil
Instituto do Coração - HCFMUSP
São Paulo, , Brazil
Peter Lougheed Centre
Calgary, Alberta, Canada
Vancouver General Hospital
Vancouver, British Columbia, Canada
London Health Sciences Centre
London, Ontario, Canada
Centre Hospitalier de l'Université Laval
Sainte-Foy, Quebec, Canada
Vseobecna fakultni nemocnice v Praze
Prague, , Czechia
Institut klinicke a experimentalni mediciny
Prague, , Czechia
Universitatsklinkum Carl Gustav Carus an der Tu
Dresden, , Germany
Universitatsklinikum Hamburg Eppendorf
Hamburg, , Germany
Thorax Klinik
Heidelberg, , Germany
Hadassah University Hospital Ein Kerem
Jerusalem, , Israel
Rabin Medical Center
Petah Tikva, , Israel
Nippon Medical School Hospital
Tokyo, Bunkyo-ku, Japan
Kobe University Hospital
Kobe, Hyōgo, Japan
Kitasato University Hospital
Sagamihara, Kanagawa, Japan
Kyorin University Hospital
Tokyo, Mitaka-shi, Japan
National Hospital Organization Okayama Medical Center
Okayama, Okayama-ken, Japan
Chiba University Hospital
Chiba, , Japan
Hokkaido University Hospital
Sapporo, , Japan
Kurume University Medical Center
Sendai, , Japan
National Cerebral and Cardiovascular Center
Suita, , Japan
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Mexico City, Mexico City, Mexico
Instituto Nacional de Cardiologia Dr. Ignacio Chavez
Mexico City, Mexico City, Mexico
Hospital Universitario Dr. Jose Eleuterio Gonzalez
Nuevo León, Monterrey, Mexico
Unidad de Investigación Clínica En Medicina SC
Monterrey, Nuevo León, Mexico
Vrije Universiteit Amsterdam
Amsterdam, North Holland, Netherlands
Philippine Heart Center
Quezon City, National Capital Region, Philippines
Makati Medical Center
Makati, , Philippines
Philippine General Hospital (PGH)
Manila, , Philippines
Hospital Universitario Marques de Valdecilla
Santander, Cantabria, Spain
Hospital Universitario Vall d'Hebron
Barcelona, , Spain
Hospital Universitario 12 de Octubre
Madrid, , Spain
Hospital Universitario Puerta de Hierro
Majadahonda, , Spain
Hospital Virgen de La Salud
Toledo, , Spain
Golden Jubilee National Hospital
Glasgow, , United Kingdom
Royal Free Hospital
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol: US Protocol
Document Type: Study Protocol: Japan Protocol
Document Type: Study Protocol: UK Protocol
Document Type: Study Protocol: Germany Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RTA 402-C-1602
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.